Cooling catheter for acute pancreatitis
Treatments studied
Part of Digestive system clinical trials.
This trial tests a special cooling catheter placed in the body to reduce inflammation during severe pancreatitis. It may help patients who are sick enough to need hospital care but have not had pancreatitis before or other major health issues.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have been diagnosed with acute pancreatitis and are in the hospital for it.
- Your symptoms started within the last 2 days so the catheter can be placed in time.
- You have signs of systemic inflammation (like fever, fast heart rate, fast breathing, or abnormal white blood cell count).
- You have not had chronic pancreatitis or severe pancreatitis requiring procedures before.
- You do not have serious kidney, heart, stomach, or bleeding problems, and you are not on blood thinners.
- You are not currently taking GLP-1 medications like Ozempic or Mounjaro.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at whether an upper endoscopy (a camera test to look inside your stomach and the first part of your small intestine) done within 24-48 hours of being admitted to the hospital can help guide treatment for acute pancreatitis. You may be able to join if you are an adult with a confirmed case of acute pancreatitis and are able to safely undergo this procedure.
This study tests whether heparin, a blood-thinning medication, can help prevent organ damage in people with acute pancreatitis (sudden severe pancreas inflammation). Researchers believe heparin may reduce the risk of serious complications like organ failure.
This study tests whether giving IV fluids based on how your heart responds can improve recovery from acute pancreatitis, compared with usual care. It may help your body handle fluids better during treatment.
This trial tests whether an epidural (a numbing shot near the spine) can reduce pain and improve recovery in people with severe pancreatitis who have early problems with their lungs, heart, or kidneys. It is designed for people in the intensive care unit.
This trial compares whether patients with mild acute pancreatitis (sudden pancreas inflammation) can safely recover at home with outpatient visits instead of staying in the hospital. The goal is to see if home care is as effective and safe as inpatient care for patients with mild cases.
This study looks at whether a blood test that combines a type of white blood cell (neutrophil) and a kidney measure (creatinine) can help predict how severe acute pancreatitis is and what the outcome might be for patients.
Hear when a new Acute Pancreatitis (AP) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.